First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia
- 31 August 2011
- journal article
- Published by Elsevier BV in Placenta
- Vol. 32 (8), 598-602
- https://doi.org/10.1016/j.placenta.2011.05.006
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restrictionPlacenta, 2011
- First‐trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early‐onset pre‐eclampsiaBJOG: An International Journal of Obstetrics and Gynaecology, 2010
- First-trimester markers for the prediction of pre-eclampsia in women with a-priori high riskUltrasound in Obstetrics & Gynecology, 2010
- Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsiaPrenatal Diagnosis, 2009
- First-trimester maternal serum PP13 in the risk assessment for preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2008
- Evaluation of Logistic Regression Reporting in Current Obstetrics and Gynecology LiteratureObstetrics & Gynecology, 2008
- Low levels of maternal serum PAPP‐A in the first trimester and the risk of pre‐eclampsiaPrenatal Diagnosis, 2007
- First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restrictionAmerican Journal of Obstetrics and Gynecology, 2007
- First‐trimester maternal serum PP‐13, PAPP‐A and second‐trimester uterine artery Doppler pulsatility index as markers of pre‐eclampsiaUltrasound in Obstetrics & Gynecology, 2006
- A novel approach to first‐trimester screening for early pre‐eclampsia combining serum PP‐13 and Doppler ultrasoundUltrasound in Obstetrics & Gynecology, 2005